Gilead

Six Things to Watch at Biotech CEO Conference
Minyanville
Mon, 02/11/13 - 11:10 am
BIO CEO Conference
ONYX Pharmaceuticals
Celgene
Gilead
Biomarin
Eli Lilly
Keryx
Arena Pharmaceuticals
Orexigen
Gilead Earnings Blaze a Star-Studded Future
Motley Fool
Tue, 02/5/13 - 10:39 am
earnings
Gilead
Gilead's 2 hepatitis C drug trials meet study goals
Reuters
Mon, 02/4/13 - 12:17 pm
Gilead
hepatitis C
Neutrino
Fission
Gilead Sciences: A Great Long-Term Buy And Heading Bullishly Into Earnings
Seeking Alpha
Sat, 02/2/13 - 11:49 am
Gilead
earnings
Gilead Seeks Blood Cancer Drugs to Bolster HIV Business
Bloomberg
Fri, 02/1/13 - 12:06 pm
Gilead
HIV
leukemia
Forbes Earnings Preview: Gilead Sciences
Forbes
Wed, 01/30/13 - 01:00 pm
earnings
Gilead
Should Gilead's quad pill get an exclusivity extension from FDA?
Fierce Pharma
Fri, 01/25/13 - 10:44 am
Quad
Gilead
FDA
HIV
Gilead Petitions FDA Over Its Stribild AIDS Med
Pharmalot
Thu, 01/24/13 - 10:39 am
FDA
Stribild
AIDS
Gilead
YM Biosciences says ISS, Glass Lewis endorse Gilead deal
The Fly on the Wall
Fri, 01/18/13 - 10:22 am
YM BioSciences
Gilead
M&A
Patients laud Lundbeck, Gilead, but give pharma's rep low marks
Fierce Pharma
Mon, 01/14/13 - 01:15 pm
patients
Lundbeck
Gilead
3 Biotech Stocks You Can Buy in 2013
Motley Fool
Fri, 01/4/13 - 11:16 am
Gilead
Exelixis
Dendreon
A Bio-Pharmaceutical Trailblazer Up 77% in 2012
Motley Fool
Thu, 01/3/13 - 11:29 am
Gilead
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
Achillion: Poised For Growth And Now Is The Time To Buy
Seeking Alpha
Wed, 01/2/13 - 11:47 am
Achillion
Abbott Labs
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Vertex Pharmaceuticals
2 BioPharma Stocks To Consider: Data & Facts
Motley Fool
Fri, 12/28/12 - 11:41 am
Abbott Labs
Gilead
Eli Lilly
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
hepatitis C
Vertex Pharmaceuticals
Gilead
Merck
Abbott Labs
Achillion
GSK
JNJ
Idenix
Bristol-Myers Squibb
Gilead A Strong Buy On New HIV Treatments
Motley Fool
Sat, 12/22/12 - 12:16 pm
Gilead
HIV
Stribild
Gilead, Abbott should benefit from first mover HCV advantage, says Wells Fargo
Yahoo/Fly on the Wall
Mon, 12/17/12 - 01:13 pm
Gilead
Abbott Labs
hepatitis C
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
hepatitis C
Achillion
Gilead
Idenix
Merck
Medivir
Vertex Pharmaceuticals
Teva Won’t Sell Gilead Generics Until June or Ruling
Bloomberg
Wed, 11/28/12 - 10:38 am
Teva
generics
Gilead

Pages